HomePage Banners

Social Pillar

CESlink: Online cooperation between economic and social councils Malta - Presidency of the Council of the European Union

EMAS - Verified environmental management

Register of documents

 

ISO14001 certified Vinçotte W3C - WAI-AA - WCAG 2.0

Delivering safe information on medicinal products in Europe Public Hearing - Brussels, Belgium

Draft programme

9.00 ǀ Registration of participants

9.30 - 13.00 Public hearing:

Welcome

  • Mr Peter Morgan, President of the Study group

Introduction

Cooperation towards electronic patient information

  • Ms Terje Peetso, Programme Officer, European Commission, DG CNECT

Innovative Medicines Initiative (IMI): digital information

  • Mr Colm Carroll, Scientific Project Manager, Innovative Medicines Initiative

Implications of the Innovative Medicines Initiative (IMI) for patients – how to better communicate information on medicines for children

  • Mr Francis P. Crawley, Executive Director, Good Clinical Practice Alliance - Europe (GCPA)

Existing electronic information systems at national level

  • Ms Elizabeth Kuiper, Director, European Affairs, European Federation of Pharmaceutical Industries and Associations (EFPIA)

Mobile devices and Apps in a medical context

  • Dr.med. Urs-Vito Albrecht, Hannover Medical School

Patients’ expectations for the future of medicinal product information

  • Mr David Haerry, Co-Chair Patient and Consumer Working Party, EMA, Executive Committee EUPATI-IMI, Board of Directors, European AIDS treatment group

Coffee break

Floor requests and open debate

Summing up and closing remarks

  • Ms Renate Heinisch
  • Mr Peter Morgan

End of the hearing